Bufalin enhances anti-angiogenic effect of sorafenib via AKT/VEGF signaling. [electronic resource]
Producer: 20161110Description: 1229-41 p. digitalISSN:- 1791-2423
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Aorta -- pathology
- Apoptosis
- Bufanolides -- administration & dosage
- Cell Cycle
- Cell Movement
- Cell Proliferation
- Cell Survival
- Chick Embryo
- Cytokines -- metabolism
- Drug Synergism
- Enzyme Inhibitors -- administration & dosage
- Enzyme-Linked Immunosorbent Assay
- Human Umbilical Vein Endothelial Cells
- Humans
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Neovascularization, Pathologic
- Niacinamide -- administration & dosage
- Phenylurea Compounds -- administration & dosage
- Proto-Oncogene Proteins c-akt -- metabolism
- Random Allocation
- Rats
- Signal Transduction
- Sorafenib
- Vascular Endothelial Growth Factor A -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.